NCT05594667View on ClinicalTrials.gov

Effect of SSRIs on Response to Psilocybin Therapy

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 1, 2023

Primary Completion Date

March 14, 2023

Study Completion Date

March 14, 2023

Conditions
DepressionMajor Depressive DisorderMild DepressionModerate DepressionDepressive Disorder
Interventions
DRUG

Psilocybin

25mg of psilocybin provided by Filament Health

Trial Locations (1)

V2T 2X5

Centre for Neurology Studies x Upstream, Abbotsford

Sponsors
All Listed Sponsors
lead

Cybin Therapeutics Inc.

INDUSTRY

NCT05594667 - Effect of SSRIs on Response to Psilocybin Therapy | Biotech Hunter | Biotech Hunter